Boiron SA (BOI) Stock Price & News

Why is BOI up 2.05%?

Dive Deeper

BOI:EPA

Boiron SA

€19.90

+2.05%

(+0.40) 1D

ኖቬም 6, 5:35:11 ከሰዓት ጂ ኤም ቲ+1 · EUR

All symbols

	Symbol	Price	Change	% Change

Generating top insights for BOI...

Open

€19.90

High

€19.90

Low

€19.20

Mkt. cap

350.39 ሚ

Avg. vol.

4.95 ሺ

Volume

4.25 ሺ

P/E ratio

13.19

52-wk high

€32.25

52-wk low

€16.90

EPS

€1.51

Shares outstanding

17.55 ሚ

No. of employees

3 ሺ

Open

€19.90

High

€19.90

Low

€19.20

Mkt. cap

350.39 ሚ

Avg. vol.

4.95 ሺ

Volume

4.25 ሺ

P/E ratio

13.19

52-wk high

€32.25

52-wk low

€16.90

EPS

€1.51

Shares outstanding

17.55 ሚ

No. of employees

3 ሺ

Related stocks

Bank of East Asia Ltd

News stories

From web sources and news partners

Yahoo Finance

ከ16 ደቂቃዎች በፊት

Dow, S&P 500, Nasdaq Futures Rebound After Sharp AI Selloff Last Week: NVDA, AMD, VIR, SNDK In Focus

Yahoo Finance

ከ53 ደቂቃዎች በፊት

Galaxy Digital (NasdaqGS:GLXY) Stock Fair Value Edges Lower As Analysts Weigh AI Buildout Risks

CryptoRank

ከ30 ደቂቃዎች በፊት

S&P 500 Earnings Beats Shrink to Just 2.7%, Weakest in Four Years Despite 84% of Companies Topping Forecasts

Bloomberg

ከ1 ሰዓት በፊት

Asian Markets at Risk of Pressure on Nvidia Probe: Markets Wrap

Profile

Boiron is a manufacturer of homeopathic products, headquartered in France and with an operating presence in 59 countries worldwide. It is the largest manufacturer of homeopathic products in the world. In 2004, it had a workforce of 2,779 and turnover of € 313 million. It is a member of the CAC Small stock index. In June 2005, the firm acquired Dolisos Laboratories, then the world's second largest manufacturer of homeopathic preparations. Products of Boiron include mono- and poly-preparations, which Boiron refer to as "proprietary drugs". Homeopathy is a pseudoscience with no evidence of effectiveness for stated claims or plausible mechanism of medicinal effect, and several class action lawsuits have been filed on behalf of consumers claiming that Boiron's homeopathic products, including Children's Coldcalm and Oscillococcinum, are useless and Boiron's marketing of these products is deceptive. Wikipedia

About Boiron SA

CEO-

Employees2.62 ሺ

Founded7 ጁን 1932

Headquarters-

SectorHealth Care

IndustryPharmaceutical industry

Websiteboiron.fr

All values in EUR	ሴፕቴ 2025	ዲሴም 2025	ማርች 2026	ጁን 2026
Revenue	127.73 ሚ	127.73 ሚ	120.16 ሚ	120.16 ሚ
Cost of goods sold	35.40 ሚ	35.40 ሚ	33.53 ሚ	33.53 ሚ
Cost of revenue	35.40 ሚ	35.40 ሚ	33.53 ሚ	33.53 ሚ
Research and development expenses	1.56 ሚ	1.56 ሚ	1.44 ሚ	1.44 ሚ
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	79.26 ሚ	79.26 ሚ	79.95 ሚ	79.95 ሚ
Operating expense	77.52 ሚ	77.52 ሚ	81.88 ሚ	81.88 ሚ
Total operating expenses	112.92 ሚ	112.92 ሚ	115.41 ሚ	115.41 ሚ
Operating income	14.81 ሚ	14.81 ሚ	4.76 ሚ	4.76 ሚ
Other non operating income	-1.13 ሚ	-1.13 ሚ	-2.29 ሚ	-2.29 ሚ
EBT including unusual items	13.82 ሚ	13.82 ሚ	4.02 ሚ	4.02 ሚ
EBT excluding unusual items	13.16 ሚ	13.16 ሚ	2.75 ሚ	2.75 ሚ
Income tax expense	3.18 ሚ	3.18 ሚ	1.56 ሚ	1.56 ሚ
Effective tax rate	22.99%	22.99%	38.90%	38.90%
Other operating expenses	-3.30 ሚ	-3.30 ሚ	488.00 ሺ	488.00 ሺ
Net income	10.64 ሚ	10.64 ሚ	2.46 ሚ	2.46 ሚ
Net profit margin	8.33%	8.33%	2.04%	2.04%
Earnings per share	-	-	-	-
Interest and investment income	653.00 ሺ	653.00 ሺ	636.50 ሺ	636.50 ሺ
Interest expense	-335.00 ሺ	-335.00 ሺ	-410.00 ሺ	-410.00 ሺ
Net interest expenses	318.00 ሺ	318.00 ሺ	226.50 ሺ	226.50 ሺ
Depreciation and amortization charges	-	-	-	-
EBITDA	18.06 ሚ	18.06 ሚ	11.17 ሚ	11.17 ሚ
Gain or loss from assets sale	-446.00 ሺ	-446.00 ሺ	-	-

Ask anything